Inhibition of High-Temperature Requirement Protein A2 Protease Activity Represses Myogenic Differentiation via UPRmt

• Published in: International journal of molecular sciences 2022-10, Vol.23 (19), p.11761
• Main Authors: Sun, Hongyu, Shen, Luyan, Zhang, Ping, Lin, Fu, Ma, Jiaoyan, Wu, Ying, Yu, Huimei, Sun, Liankun
• Format: Article
• Language: English
• Subjects: Biosynthesis; Cell cycle; Cell differentiation; Cells (biology); Differentiation; Experiments; Gene expression; High temperature; Homeostasis; HtrA2/Omi; Hypotheses; Mitochondria; Mitochondrial DNA; mitonuclear imbalance; Muscles; Musculoskeletal system; Myoblasts; Myogenesis; Phenotypes; Phosphorylation; Physiology; Protease; Protein folding; Proteinase; Proteins; Replenishment; Retrograde transport; RNA polymerase; Sarcopenia; Satellite cells; Signal transduction; Skeletal muscle; Temperature requirements; Transcription factors; UPRmt
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms231911761

Skeletal muscles require muscle satellite cell (MuSC) differentiation to facilitate the replenishment and repair of muscle fibers. A key step in this process is called myogenic differentiation. The differentiation ability of MuSCs decreases with age and can result in sarcopenia. Although mitochondria have been reported to be involved in myogenic differentiation by promoting a bioenergetic remodeling, little is known about the interplay of mitochondrial proteostasis and myogenic differentiation. High-temperature-requirement protein A2 (HtrA2/Omi) is a protease that regulates proteostasis in the mitochondrial intermembrane space (IMS). Mice deficient in HtrA2 protease activity show a distinct phenotype of sarcopenia. To investigate the role of IMS proteostasis during myogenic differentiation, we treated C2C12 myoblasts with UCF101, a specific inhibitor of HtrA2 during differentiation process. A key step in this process is called myogenic differentiation. The differentiation ability of MuSCs decreases with age and can result in sarcopenia. Further, CHOP, p-eIF2α, and other mitochondrial unfolded protein response (UPRmt)-related proteins are upregulated. Therefore, we suggest that imbalance of mitochondrial IMS proteostasis acts via a retrograde signaling pathway to inhibit myogenic differentiation via the UPRmt pathway. These novel mechanistic insights may have implications for the development of new strategies for the treatment of sarcopenia.